Tesla's 30-day narrative reflects institutional tension between delivery fundamentals and valuation compression within the mega-cap tech cohort. Morgan Stanley's upward Q2 delivery revision to 413,000 units signals stronger Europe-China demand, while JPMorgan's simultaneous downward estimate revision signals execution risk concerns. The stock absorbed a 13% monthly decline amid the broader "mega rotation" exiting concentrated tech holdings, with institutional capital systematically redeploying toward lagging sectors. Critical near-term catalysts center on Tesla's early-July Q2 delivery announcement, which the market views as subordinate to robotaxi disclosures. Berlin facility expansion to 7,500 weekly units by October demonstrates production confidence. However, macro headwinds dominate: the Magnificent 7 cohort experiences material underperformance, signaling growth-narrative fatigue and valuation compression across high-multiple names. Solar roofing integration represents tactical bundling rather than transformative revenue. Forward trajectory hinges on Tesla's ability to sustain delivery growth amid sector-wide capital rotation, with Q2 numbers likely repricing near-term expectations.